Repka T - Search Results

1

Peripheral blood versus bone marrow for hematopoietic cell transplantation.

Repka T, Weisdorf D. Repka T, et al. Curr Opin Oncol. 1998 Mar;10(2):112-7. doi: 10.1097/00001622-199803000-00005. Curr Opin Oncol. 1998. PMID: 9555532 Review.

2

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.

Burns LJ, Weisdorf DJ, DeFor TE, Repka TL, Ogle KM, Hummer C, Miller JS. Burns LJ, et al. Among authors: repka tl. Exp Hematol. 2000 Jan;28(1):96-103. doi: 10.1016/s0301-472x(99)00129-0. Exp Hematol. 2000. PMID: 10658681 Free article. Clinical Trial.

3

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. Burns LJ, et al. Among authors: repka tl. Bone Marrow Transplant. 2003 Jul;32(2):177-86. doi: 10.1038/sj.bmt.1704086. Bone Marrow Transplant. 2003. PMID: 12838283 Clinical Trial.

4

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.

Markova M, Barker JN, Miller JS, Arora M, Wagner JE, Burns LJ, MacMillan ML, Douek D, DeFor T, Tan Y, Repka T, Blazar BR, Weisdorf DJ. Markova M, et al. Among authors: repka t. Bone Marrow Transplant. 2007 Feb;39(4):193-9. doi: 10.1038/sj.bmt.1705556. Epub 2007 Jan 15. Bone Marrow Transplant. 2007. PMID: 17220905 Clinical Trial.

5

Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature.

Haddad PA, Repka TL, Weisdorf DJ. Haddad PA, et al. Among authors: repka tl. Am J Med. 2002 Aug 1;113(2):152-5. doi: 10.1016/s0002-9343(02)01154-3. Am J Med. 2002. PMID: 12133754 Review. No abstract available.

6

Nonmyeloablative HPC transplantation.

Repka T, Weisdorf DJ. Repka T, et al. Transfusion. 2000 Jul;40(7):758-60. doi: 10.1046/j.1537-2995.2000.40070758.x. Transfusion. 2000. PMID: 10924601 No abstract available.

7

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

Cooley S, Burns LJ, Repka T, Miller JS. Cooley S, et al. Among authors: repka t. Exp Hematol. 1999 Oct;27(10):1533-41. doi: 10.1016/s0301-472x(99)00089-2. Exp Hematol. 1999. PMID: 10517495 Free article.

8

Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red cell.

Sugihara T, Repka T, Hebbel RP. Sugihara T, et al. Among authors: repka t. J Clin Invest. 1992 Dec;90(6):2327-32. doi: 10.1172/JCI116121. J Clin Invest. 1992. PMID: 1469090 Free PMC article.

9

Hydroxyl radical formation by sickle erythrocyte membranes: role of pathologic iron deposits and cytoplasmic reducing agents.

Repka T, Hebbel RP. Repka T, et al. Blood. 1991 Nov 15;78(10):2753-8. Blood. 1991. PMID: 1668610 Free article.

10

Trastuzumab and interleukin-2 in HER2-positive metastatic breast cancer: a pilot study.

Repka T, Chiorean EG, Gay J, Herwig KE, Kohl VK, Yee D, Miller JS. Repka T, et al. Clin Cancer Res. 2003 Jul;9(7):2440-6. Clin Cancer Res. 2003. PMID: 12855616 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters